We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

193 hedge funds and large institutions have $581M invested in Sage Therapeutics in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 54 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

363% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $2.18M

41% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 54

5% less funds holding

Funds holding: 204 → 193 (-11)

8.37% less ownership

Funds ownership: 97.3% → 88.92% (-8.4%)

20% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 40

47% less capital invested

Capital invested by funds: $1.1B → $581M (-$516M)

Holders
193
Holders Change
-11
Holders Change %
-5.39%
% of All Funds
2.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
76
Reduced
54
Closed
40
Calls
$10.1M
Puts
$2.18M
Net Calls
+$7.92M
Net Calls Change
+$5.82M

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$11.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$8.59M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.52M
4
Invesco
Invesco
Georgia
+$7.38M
5
Renaissance Technologies
Renaissance Technologies
New York
+$6.64M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$60.4M
2
State Street
State Street
Massachusetts
-$25.9M
3
Deutsche Bank
Deutsche Bank
Germany
-$12.9M
4
SC
Samlyn Capital
New York
-$11.1M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
151
Amalgamated Bank
New York
$19K – – –
CFGS
152
Concourse Financial Group Securities
Alabama
$10.9K – – –
PGAM
153
Princeton Global Asset Management
New Jersey
$10.9K – – –
Carson Wealth (CWM LLC)
154
Carson Wealth (CWM LLC)
Nebraska
$9K +$5.55K +433 +104%
Pacer Advisors
155
Pacer Advisors
Pennsylvania
$7.61K -$14.4K -1,125 -62%
Osaic Holdings
156
Osaic Holdings
Arizona
$7.24K -$73.2K -5,715 -90%
NECFA
157
New England Capital Financial Advisors
Connecticut
$7.06K +$6.61K +516 +385%
Acadian Asset Management
158
Acadian Asset Management
Massachusetts
$6K +$7.51K +586 New
MCM
159
Manchester Capital Management
Vermont
$5.97K +$7.05K +550 New
CM
160
Caption Management
Oklahoma
$5.43K -$56.3K -4,390 -90%
LC
161
Lindbrook Capital
California
$4.99K +$3.34K +261 +132%
S
162
SignatureFD
Georgia
$4.84K +$1.29K +101 +29%
PNC Financial Services Group
163
PNC Financial Services Group
Pennsylvania
$4.14K -$4.45K -347 -48%
QCG
164
Quadrant Capital Group
Ohio
$3.65K +$4.3K +336 New
Daiwa Securities Group
165
Daiwa Securities Group
Japan
$3K – – –
RIL
166
Rothschild Investment LLC
Illinois
$2.93K +$192 +15 +6%
RTL
167
Red Tortoise LLC
Georgia
$1.77K +$2.09K +163 New
PA
168
Parallel Advisors
California
$1.65K -$10.7K -836 -85%
AF
169
Allworth Financial
California
$1.62K +$38 +3 +2%
CIBC Private Wealth Group
170
CIBC Private Wealth Group
Georgia
$1.53K – – –
GI
171
GAMMA Investing
California
$1.46K +$231 +18 +16%
TFM
172
TFC Financial Management
Massachusetts
$1.1K +$1.29K +101 New
SSB
173
Sandy Spring Bank
Maryland
$1.09K – – –
Jones Financial Companies
174
Jones Financial Companies
Missouri
$1.09K +$1.28K +100 New
AAP
175
Arax Advisory Partners
Colorado
$1.05K +$1.24K +97 New
5 6
7
8 9

SAGE Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q2 2024, worth a combined $581M — down 47% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of SAGE and 32 opened new positions — a net loss of 8 holders — while 54 trimmed existing stakes and 76 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $11.1M. The largest seller was Wellington Management Group, cutting an estimated $60.4M.

  • 193 institutional investors held Sage Therapeutics (SAGE) as of Q2 2024, down from 204 in Q1 2024.
  • Funds reported $581M of Sage Therapeutics stock for Q2 2024, down 47% quarter-over-quarter.
  • 32 funds opened new Sage Therapeutics positions in Q2 2024 and 40 closed out, a net change of -8 holders.
  • The largest Sage Therapeutics buyer in Q2 2024 was Jacobs Levy Equity Management, an estimated $11.1M added.
  • The largest Sage Therapeutics seller in Q2 2024 was Wellington Management Group, an estimated $60.4M sold.

Based on aggregated 13F filings for Q2 2024.